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Relief of the Dma1-mediated checkpoint requires 
Dma1 autoubiquitination and dynamic 
localization
ABSTRACT Chromosome segregation and cell division are coupled to prevent aneuploidy 
and cell death. In the fission yeast Schizosaccharomyces pombe, the septation initiation net-
work (SIN) promotes cytokinesis, but upon mitotic checkpoint activation, the SIN is actively 
inhibited to prevent cytokinesis from occurring before chromosomes have safely segregated. 
SIN inhibition during the mitotic checkpoint is mediated by the E3 ubiquitin ligase Dma1. 
Dma1 binds to the CK1-phosphorylated SIN scaffold protein Sid4 at the spindle pole body 
(SPB), and ubiquitinates it. Sid4 ubiquitination antagonizes the SPB localization of the Polo-
like kinase Plo1, the major SIN activator, so that SIN signaling is delayed. How this checkpoint 
is silenced once spindle defects are resolved has not been clear. Here we establish that Dma1 
transiently leaves SPBs during anaphase B due to extensive autoubiquitination. The SIN is 
required for Dma1 to return to SPBs later in anaphase. Blocking Dma1 removal from SPBs by 
permanently tethering it to Sid4 prevents SIN activation and cytokinesis. Therefore, control-
ling Dma1’s SPB dynamics in anaphase is an essential step in S. pombe cell division and the 
silencing of the Dma1-dependent mitotic checkpoint.
INTRODUCTION
Accurate cell division, yielding two genetically identical daughter 
cells, requires coordination between mitosis and cytokinesis. In the 
fission yeast Schizosaccharomyces pombe, the septation initiation 
network (SIN), a protein kinase cascade, coordinates these two 
events by initiating cytokinesis after chromosome segregation (for 
review see Krapp and Simanis, 2008; Johnson et al., 2012b; Simanis, 
2015). When there is a mitotic error, a checkpoint mechanism inhib-
its SIN signaling to prevent cytokinesis from occurring before chro-
mosomes have safely segregated (Marks et al., 1992; Murone and 
Simanis, 1996; Guertin et al., 2002; Johnson and Gould, 2011). This 
checkpoint operates in parallel to the spindle assembly checkpoint 
(Murone and Simanis, 1996; Johnson et al., 2013; Musacchio, 
2015). Checkpoints with the similar purpose of maintaining coordi-
nation between chromosome segregation and cytokinesis also ex-
ist in Saccharomyces cerevisiae and mammals (Mendoza and Barral, 
2008; Caydasi and Pereira, 2012; Nahse et al., 2017).
SIN inhibition during a mitotic error depends on the dimeric E3 
ubiquitin ligase Dma1, a member of the FHA and RING finger family 
(Brooks et al., 2008). Dma1 was identified as a high copy suppressor 
of a hyperactive SIN mutant, and it is required to prevent septation 
during a prometaphase arrest elicited by the ß-tubulin mutant nda3-
km311 (Hiraoka et al., 1984; Murone and Simanis, 1996). Overpro-
duction of Dma1 completely blocks SIN activity and results in cell 
death (Guertin et al., 2002), indicating its levels and activity must be 
properly regulated. Dma1 colocalizes with SIN components both at 
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(Guertin et al., 2002); however, it is Dma1’s SPB localization and its 
ubiquitination of the SIN scaffold protein, Sid4 (Chang and Gould, 
2000; Morrell et al., 2004), that is required for SIN inhibition during a 
mitotic checkpoint (Johnson and Gould, 2011). Sid4 ubiquitination 
antagonizes the SPB localization of the Polo-like kinase Plo1 (Guertin 
et al., 2002; Johnson and Gould, 2011), the major SIN activator 
(Ohkura et al., 1995; Mulvihill et al., 1999; Tanaka et al., 2001), so that 
SIN signaling is blocked and cytokinesis is delayed.
Upon resolution of the mitotic spindle defect, the Dma1-depen-
dent checkpoint signal must be extinguished to resume SIN activa-
tion and cell division. Here we report that Dma1 exhibits striking 
fluctuations in its localization to SPBs and the division site during the 
cell cycle. We found that both SIN activity and Dma1 autoubiquiti-
nation modulate Dma1 SPB localization dynamics and therefore its 
ability to inhibit the SIN. By permanently tethering Dma1 to SPBs 
and preventing these fluctuations, the SIN fails to become active 
and cytokinesis is blocked. Therefore, Dma1’s dynamic SPB localiza-
tion is a critical feature of S. pombe cytokinesis and silencing of the 
mitotic checkpoint.
RESULTS
Dma1’s E3 ligase activity impacts its abundance and 
localization
Consistent with previous literature (Guertin et al., 2002; Johnson 
and Gould, 2011), we observed that Dma1 tagged at its endoge-
nous locus with mNeonGreen (mNG) (Shaner et al., 2013; Willet 
et al., 2015) (Figure 1A) concentrates at SPBs during mitosis, where 
it is required for SIN inhibition (Guertin et al., 2002). We also ob-
served localization at cell tips during interphase and at the division 
site during mitosis and cytokinesis. Given that wild-type Dma1 did 
not appear to localize to SPBs during the majority of interphase 
(Figure 1A), we sought to identify the mechanism(s) that influences 
Dma1 SPB targeting and SIN inhibition.
Because Dma1 localization changes over the course of the cell 
cycle, we undertook time-lapse imaging experiments to clarify the 
timing of Dma1 localization to the SPB and cell division site. Dma1-
mNG became enriched at SPBs prior to SPB separation (Figure 1B 
and Supplemental Figure S1A). Unexpectedly, at the onset of 
mitosis, Dma1-mNG appeared in nodelike structures, a pattern pre-
viously undetected for Dma1 (Guertin et al., 2002), that partially 
overlapped with cytokinetic precursor nodes marked by Rlc1 (Rincon 
and Paoletti, 2012), before forming a ring at the division site (Figure 
1B and Supplemental Figure S1B). Then Dma1-mNG appeared to 
transiently leave SPBs during anaphase B, returning to them before 
telophase and then leaving again after cell division (Figure 1, B and 
C, and Supplemental Figure S1C). In 24 of 28 (86%) mitotic SPBs, 
Dma1-mNG signal transiently dimmed or became undetectable, 
whereas the SPB markers Sid4-mCherry or Sad1-mCherry did not. 
Dma1 SPB dimming occurred within 2 min of anaphase B onset in 
90% of cells exhibiting this phenomenon, and it returned to SPBs in 
all cases before the end of anaphase B, marked by maximal SPB 
separation, and then left again at cell division. In a few cases, the 
Dma1 signal was observed to “flicker” on and off a SPB during ana-
phase B and to shift in intensity between the two SPBs.
Similarly, Dma1-mNG was observed to leave and then return to 
the division site although with delayed kinetics (min 18–26) com-
pared with what was observed at SPBs (min 14–16) (Figure 1, B and 
C, and Supplemental Figure S1, A and B). The role of Dma1 at the 
division site is not yet understood because no binding partners or 
substrates at the medial cortex have been identified.
Interestingly, in contrast to wild-type Dma1, we found that the 
Dma1-I194A mutant, which lacks ubiquitin ligase activity due to a 
mutation in the RING-finger domain (Johnson and Gould, 2011), 
was detectable at SPBs throughout the cell cycle when it was tagged 
with mNG (Figure 1D) or GFP (unpublished data) at its C-terminus, 
or either fluorophore at its N-terminus (unpublished data). Dma1-
I194A-mNG signal persisted at SPBs throughout the cell cycle, only 
detectably dimming at 14% of mitotic SPBs, although its dynamic 
localization at the cell division site appeared like wild type (Figure 
1E and Supplemental Figure S1). Also, in 20 of 20 cells Dma1-I194A-
mNG localized more intensely at one of the two SPBs for most of 
mitosis (Figure 1, E and F). Thus, Dma1 localization is more dynamic 
than previously appreciated, and Dma1 catalytic activity affects its 
SPB dynamics. Because Dma1 activity does not impact its cell divi-
sion site localization dynamics, a different mechanism of targeting to 
this site must be in place.
Sid4 ubiquitination does not impact Dma1 accumulation 
at SPBs
To determine why Dma1-I194A was less dynamic at SPBs during 
mitosis than Dma1, we examined whether the ubiquitination status 
of either of Dma1’s two known substrates, Sid4 and Dma1 itself 
(Johnson and Gould, 2011), modulated its localization. To investi-
gate whether the absence of Sid4 ubiquitination promoted Dma1 
localization to SPBs, we first needed to develop a strain in which 
Sid4 ubiquitination was abrogated. The canonical approach is to 
replace target lysines with arginines; however, previous attempts to 
construct such a Sid4 variant were unsuccessful (Johnson and Gould, 
2011; Johnson et al., 2013). We therefore turned to a method de-
scribed previously to eliminate ubiquitination of a protein of inter-
est—fusion to a deubiquitinating enzyme (DUB) catalytic domain 
(Stringer and Piper, 2011).
To identify the appropriate DUB for fusion to Sid4, we screened 
18 of the 20 S. pombe DUBs for their ability to rescue Dma1 overex-
pression-induced cytokinesis failure and cell death when the DUB 
was also overproduced (Murone and Simanis, 1996; Guertin et al., 
2002). Four of the 18 DUBs (Ubp1, Ubp2, Ubp7, and Ubp14) sup-
pressed Dma1-induced cell death when they were coordinately 
overproduced, presumably by reversing Sid4 ubiquitination. Of 
these, only Ubp7 has diffuse cytoplasmic localization and functions 
independently of other subunits in vivo (Kouranti et al., 2010), mak-
ing it well suited for our purpose. The ubiquitin specific protease 
(USP) domain of Ubp7 was fused to the C-terminus of Sid4 (Sid4-
DUB) and produced under control of the native sid4+ promoter as 
the sole version of Sid4 in the cell. The fusion did not affect cell 
viability, but the Sid4-DUB fusion was still ubiquitinated (Supple-
mental Figure S2A), indicating that the DUB was not able to access 
Sid4 ubiquitination sites.
We next tested whether adding the Ubp7 USP domain to the C-
terminus of the Sid4 binding partner Ppc89 (Rosenberg et al., 2006) 
eliminated Sid4 ubiquitination. The Ppc89-Ubp7 USP fusion (hereaf-
ter called Ppc89-DUB) abolished Sid4 ubiquitination, comparable to 
deletion of dma1 (Supplemental Figure S2B). The ppc89-DUB strain 
grew similarly to wild type at a variety of temperatures (Supplemental 
Figure S2C), and as would be expected when Sid4 cannot accumu-
late ubiquitin modifications, the ppc89-DUB strain resisted Dma1 
overexpression-induced cell death (Supplemental Figure S2D).
To determine whether lack of Sid4 ubiquitination affected Dma1-
mNG localization, we measured and compared Dma1-mNG SPB in-
tensity relative to Sad1-mCherry in wild-type and ppc89-DUB strains 
and found no difference (Supplemental Figure S2, E and F). More-
over, the dynamic localization of Dma1-mNG to the SPB and division 
site was unchanged in the ppc89-DUB strain, although mitotic pro-
gression took longer in this strain; of 22 SPBs examined in 11 cells, 
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Dma1-mNG was transiently undetectable on 17 and diminished on 5 
others during anaphase (Supplemental Figure S2, G and H). These 
data demonstrate that an absence of Sid4 ubiquitination does not 
account for the differences observed in catalytically inactive Dma1 
dynamic localization at SPBs relative to wild-type Dma1.
Dma1 exhibits promiscuous autoubiquitination in vivo 
and in vitro
In addition to displaying distinct dynamics, by comparing Dma1-
mNG and Dma1-I194A-mNG intensities normalized to the SPB 
marker Sad1-mCherry (Hagan and Yanagida, 1995), we found that 
FIGURE 1: Dynamics of Dma1 localization through the cell cycle. (A, D) Live cell images of dma1-mNG (A) and 
dma1-I194A-mNG (D). Scale bar, 5 µm. (B, E) Images from representative movies of dma1-mNG sid4-mCherry (B) and 
dma1-I194A-mNG sid4-mCherry (E). Arrows indicate Dma1 localization in cytokinetic nodelike structures. Arrowheads 
indicate Dma1 localization to cell tips. Brackets indicate times of reduced Dma1 detection at the division site. Time in 
minutes denoted below images; 0 indicates initial frame of SPB separation. Scale bars, 5 µm. (C, F) Enlarged SPB 
region(s) from movies in B and E. Scale bars, 1 µm.
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Dma1-I194A-mNG was more abundant (3.2-fold) at SPBs in both 
mitotic and septated cells compared with wild-type Dma1 (Figure 
2A). Although we did not quantitate Dma1-I194A abundance at 
the division site or cell tips, it was visibly more intense than wild-type 
Dma1 at these sites as well (Figure 1D).
To determine whether the different intensities measured at 
SPBs reflected increased abundance of Dma1-I194A relative to 
wild-type Dma1, we examined protein levels by whole cell fluores-
cence intensity and immunoblotting (Figure 2, B and C). By both 
methods, the mutant protein was 2.6-fold higher in abundance, 
indicating that inactivating the catalytic activity of Dma1 causes an 
increase in total Dma1 protein. However, the overall difference in 
protein abundance was not as high as the difference in SPB inten-
sity (2.6-fold increase vs. 3.2-fold increase) and so cannot fully 
FIGURE 2: Dma1 autoubiquitination influences its abundance and localization dynamics. (A) Quantification of Dma1-
mNG and Dma1-I194A-mNG intensities at SPBs, relative to Sad1-mCherry in mitotic or septated cells. n ≥ 42 cells for 
each measurement; error bars represent standard error determined by two-tailed Student's t test, ***p = 4.9 × 10-43 
(mitosis) and 1.3 × 10-11 (septation). A.U. = arbitrary units. (B) Quantification of Dma1-mNG and Dma1-I194A-mNG 
whole-cell fluorescence intensities in nonseptated interphase and mitotic cells or septated cells; n ≥ 20 cells for each 
measurement. Error bars represent standard error determined by two-tailed Student's t test, ***p = 1.3 × 10-7 
(interphase and mitosis) and 4.9 × 10-9 (septation). A.U. = arbitrary units. (C) Abundance of Dma1-I194A-mNG relative to 
wild-type Dma1-mNG was determined by immunoblotting. One representative blot of three independent repetitions is 
shown. (D) Dma1-HBH, Dma1-I194A-HBH, or nonspecifically purified proteins were isolated from mts3-1 cells that had 
been shifted to 36°C for 3 h. Dma1 ubiquitination was detected by immunoblotting with an antiubiquitin antibody (top 
panel) and unmodified Dma1 was detected with fluorescently labeled streptavidin (bottom panel). (E) Relative protein 
levels of Dma1 (top) in the indicated strains as determined by immunoblotting immunoprecipitates relative to Cdc2 in 
the lysates (bottom) (top panel) followed by quantification with Odyssey (bottom panel). Quantification data is average 
± SD from two independent experiments. (F) Recombinant MBP-Dma1 was incubated with an E1-activating enzyme 
and/or the E2-conjugating enzyme, UbcH5a/UBE2D1, and methylated ubiquitin. Ubiquitin-modified Dma1 was 
detected by immunoblotting with an anti-ubiquitin antibody (top panel) and unmodified Dma1 was detected with 
anti-Dma1 serum (bottom panel). (G) Recombinant MBP-Dma1 proteins were incubated with an E1-activating enzyme, 
the E2-conjugating enzyme UbcH5a/UBE2D1 and methylated ubiquitin. Dma1 was cleaved from MBP and 
autoubiquitination was detected by immunoblotting with anti-Dma1 serum. (H) Recombinant MBP-Dma1 proteins were 
incubated with an E1-activating enzyme, the E2-conjugating enzyme UbcH5a/UBE2D1, and methylated ubiquitin. 
MBP-Dma1 ubiquitination was detected by immunoblotting with anti-Dma1 serum.
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account for the increased protein and lack of dynamics of Dma1-
I194A observed at SPBs. Dma1 autoubiquitinates in vitro (Johnson 
et al., 2012a; Wang et al., 2012). Therefore, we next asked whether 
a lack of autoubiquitination in catalytically inactive Dma1-I194A 
could explain its increased SPB localization and decreased SPB 
localization dynamics.
To establish that Dma1 autoubiquitinates in vivo, Dma1 and 
Dma1-I194A, both tagged with his6-biotin-his6 (HBH), were purified 
under fully denaturing conditions and probed for the presence of 
ubiquitinated forms by immunoblotting. Using the mts3-1 protea-
some mutant to block turnover of ubiquitinated proteins, we de-
tected ubiquitin modification of wild-type Dma1 but not catalytically 
inactive Dma1-I194A (Figure 2D) (Gordon et al., 1996). Thus, Dma1 
autoubiquitinates in vivo as well as in vitro.
To test the idea that Dma1 autoubiquitination might promote its 
proteasomal degradation, we measured Dma1 levels in mts3-1 
relative to wild type and found that Dma1 was more abundant in 
mts3-1-arrested cells (Figure 2E). These data are consistent with 
autoubiquitination triggering Dma1 destruction.
To investigate directly whether ubiquitin modifications affect 
Dma1’s ability to localize to SPBs, we sought to identify and mutate 
the autoubiquitinated residues. We first examined the sites of Dma1 
autoubiquitination in vitro using recombinant Dma1 (Figure 2F) 
(Johnson et al., 2012a; Wang et al., 2012). Dma1 contains 14 lysines 
that could be targeted for autoubiquitination. A series of mutants 
containing increasing numbers of lysine to arginine mutations was 
generated recombinantly and assayed for autoubiquitination using 
methyl ubiquitin to prevent chain elongation. Though the number 
of ubiquitin moieties added to Dma1 decreased with decreasing 
availability of lysines, only lysine-less Dma1 (Dma1-14KR) was com-
pletely unmodified (Figure 2G). Dma1 also ubiquitinated its malt-
ose-binding protein (MBP) tag if the tag was not removed prior to 
the ubiquitination reaction (Figure 2H), indicating that Dma1 pro-
miscuously ubiquitinates lysines in its proximity.
To determine which Dma1 lysines are ubiquitinated in vivo, we 
performed LC-MS/MS analyses on Dma1 purified from cells at 
different cell-cycle stages. Nine ubiquitinated lysines of the 14 pos-
sible were identified (Supplemental Figures S3A-I and S4A). We 
constructed mutant strains in which the 9 identified modified lysines 
or all 14 lysines in the protein were substituted with arginine (9KR 
and 14KR, respectively). Surprisingly, both Dma1 mutants tagged 
endogenously with the HBH tag were ubiquitinated (Supplemental 
Figure S4B). The abundance of Dma1-14KR was significantly re-
duced, likely because so many mutations disrupted its structure 
(Supplemental Figure S4B). However, that both were still ubiquiti-
nated, combined with the ability of Dma1 and Dma1-14KR to ubiq-
uitinate an MBP tag in vitro (Figure 2H), suggested that tags on the 
protein could be ubiquitinated in lieu of, or in addition to, Dma1 
lysines. Indeed, LC-MS/MS analyses of Dma1-TAP and Dma1-HBH 
purified from cells identified ubiquitinated lysine residues in both 
tags (Supplemental Figure S3, J and K), confirming that Dma1 ubiq-
uitinates its tags both in vitro and in vivo. Therefore, we predict that 
although the Dma1-9KR-mNG and Dma1-14KR mutants exhibited 
wild-type localization dynamics (Supplemental Figure S4, C and D; 
unpublished data), this is because Dma1 is still able to ubiquitinate 
the mNG tag.
We next reasoned that wild-type Dma1 would be able to autou-
biquitinate an inactive form of itself in close proximity and therefore 
restore wild-type dynamics to the catalytically inactive mutant. 
To test this, we constructed three diploid strains containing one 
mNG-tagged allele: dma1-mNG/dma1+; dma1-I194A-mNG/dma1+; 
dma1-I194A-mNG/dma1-I194A. When both alleles were wild type 
or both inactive, the localization dynamics of the tagged protein 
mirrored the haploid situation, with Dma1-mNG dimming or disap-
pearing from 100% of 20 SPBs during anaphase (Figure 3, A and D) 
and Dma1-I194A-mNG showing no change at 84% of 44 SPBs 
(Figure 3, B and E). In contrast, when Dma1-I194A-mNG was 
combined with wild-type Dma1, the tagged inactive protein now 
exhibited dynamics similar to wild type, with the Dma1-I194A-mNG 
signal dimming or disappearing at 93% of 28 SPBs during anaphase 
(Figure 3, C and F). This result indicates that the untagged wild-type 
Dma1 ubiquitinates the inactive Dma1-I194A-mNG, a reaction that 
could occur in cis or trans because Dma1 is a dimer (Johnson et al., 
2012a). These results are consistent with a model in which autoubiq-
uitination triggers the transient loss of Dma1 from SPBs during early 
anaphase B to allow SIN activation.
To test directly whether Dma1 autoubiquitination prevents its 
binding to phosphorylated Sid4, a step necessary for SIN inhibition, 
full-length Dma1 was purified from bacteria. Like the FHA domain 
alone (Johnson et al., 2013), full-length Dma1 preferentially bound 
phosphorylated Sid4 peptide (Figure 4A). When Dma1 was allowed 
to autoubiquitinate prior to the binding reaction, it did not bind the 
Sid4 phosphopeptide, and the ubiquitinated Dma1 was detected 
in the supernatant (Figure 4, A and B). To clearly detect unbound 
ubiquitinated Dma1, the supernatants of the binding reaction were 
incubated with USP2, a commercially available deubiquitinating en-
zyme that shows activity towards multiple types of ubiquitin chains 
in vitro (Komander et al., 2009). USP2 treatment allowed detection 
of Dma1 in the supernatants and confirmed that it did not bind the 
beads (Figure 4A), confirming that Dma1 can interact with Sid4 
phosphopeptide only if it is not ubiquitinated. If Dma1 was bound 
to the Sid4 phosphopeptide before the ubiquitination reaction, 
then it was released into the supernatant upon ubiquitination (Figure 
4, C and D). These data support the idea that autoubiquitination at 
the onset of anaphase B triggers Dma1 removal from phosphory-
lated Sid4 at SPBs to allow SIN activation.
Relationship between Dma1 SPB dynamics and the SIN
The dynamic localization of Dma1 during mitosis is reminiscent of 
that displayed by several SIN components (Johnson et al., 2012b; 
Simanis, 2015). Asymmetric SPB localization of Cdc7 to one SPB and 
localization of Sid2 to the division site are considered markers of 
maximal SIN activation and Cdk1 inhibition (Johnson et al., 2012b; 
Simanis, 2015). Therefore, we imaged Dma1-mNG in combination 
with those two SIN components (Figure 5) to place the timing of dy-
namic Dma1 localization in the context of SIN activation. Dma1-
mNG SPB dimming occurred 1–2 min in 14 cells and 3–5 min in three 
cells prior to the development of detectable asymmetry in Cdc7-
mCherry signal in the 17 cells examined (Figure 5, A and B), and the 
transient reduction in Dma1 division site localization preceded Sid2 
division site localization in all 8 cells examined (Figure 5C).
To test whether SIN activity modulated Dma1’s localization 
pattern, Dma1-mNG was imaged in the SIN mutant cdc7-24 as cells 
passed through mitosis. Dma1-mNG intensity dimmed or disap-
peared at 21 of 22 SPBs in 11 cells, but it never reintensified at SPBs 
as in wild-type cells (Figure 6, A and B), indicating that SIN activity is 
important for Dma1 reaccumulation at SPBs in late anaphase. Dma1 
did reintensify at the division site in all 11 cells examined. We next 
imaged Dma1-mNG in the hyperactive SIN mutant cdc16-116. In 
these cells that have constitutive SIN activity (Fankhauser et al., 
1993), Dma1-mNG was detected on 97% (116/119) of SPBs (Figure 
6C). Since in wild-type cells the SIN is not maximally active until 
Cdk1 activity falls later in anaphase (He et al., 1997; Guertin et al., 
2000; Dischinger et al., 2008), these results raise the possibility that 
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FIGURE 3: Dma1 catalytic activity drives its localization dynamics. (A–C) Images from 
representative movies of dma1-mNG/dma1+ (A), dma1-I194A-mNG/dma1-I194A (B), and 
dma1-I194A-mNG/dma1+ (C). Time in minutes denoted below images. Time 0 indicates initial 
frame of SPB separation. Scale bars, 5 µm. (D–F) Enlarged SPB region(s) from movies in A–C. 
Scale bars, 1 µm.
high SIN activity promotes Dma1 SPB reaccumulation at the end of 
anaphase.
Constitutive Dma1 localization to SPBs prevents cytokinesis
We next wanted to determine the importance of Dma1 transiently 
cycling off of SPBs during anaphase B by permanently tethering it to 
SPBs. To do this, we tagged Sid4 at its endogenous locus with GFP-
binding protein (GBP), which has a high affinity for GFP (Rothbauer 
et al., 2006, 2008). When a sid4-GBP-mCherry or sid4-GBP strain 
was crossed to dma1-GFP, many double mutants (31/35 and 7/19, 
respectively) were dead. Similarly, synthetic 
lethality was previously observed when the 
tags were reversed and dma1-GBP-mCherry 
was expressed in a sid4-GFP strain (Chen 
et al., 2017), although in this study, colocal-
ization at SPBs and dependency of cell 
death on failed cytokinesis was not deter-
mined. Fortunately, we were able to recover 
some double-tagged strains for imaging, 
although they grew very poorly: 22% of 
dma1-GFP sid4-GBP-mCherry and 11% of 
dma1-GFP sid4-GBP cells were dead or 
lysing. In live dma1-GFP sid4-GBP-mCherry 
cells, Dma1-GFP localized to the division 
site normally and colocalized with Sid4-
GBP-mCherry at SPBs at all stages of the 
cell cycle (Figure 7A), indicating that Dma1-
GFP was tethered permanently to SPBs. In 
both double mutant strains, there was a 
higher percentage of multi-nucleated cells 
than in wild type and 46% of binucleated 
cells had “kissing” nuclei (Figure 7, B–D), 
indicative of SIN failure (Hagan and Hyams, 
1988). We reasoned that if the SIN was in-
hibited in these strains via Dma1-mediated 
Sid4 ubiquitination, introducing the ppc89-
DUB fusion allele that prevents Sid4 ubiqui-
tination (Supplemental Figure S2B) should 
rescue growth of dma1-GFP sid4-GBP-
mCherry cells. As predicted, of the 14 
dma1-GFP sid4-GBP-mCherry ppc89-DUB 
triple mutant strains constructed, all were 
viable and showed reduced levels of multi-
nucleation and “kissing” nuclei (Figure 4D). 
These data indicate that constitutive associ-
ation of Dma1 with Sid4 drives Sid4 ubiqui-
tination, compromises SIN activity, and 
results in cytokinesis failure. Thus, Dma1’s 
transient loss from SPBs at the onset of ana-
phase must be a critical step in silencing the 
mitotic checkpoint, as well as allowing cyto-
kinesis to proceed in unperturbed cells.
DISCUSSION
SPB localization of the ubiquitin ligase 
Dma1 is required for its function in a mitotic 
checkpoint that stalls cytokinesis through 
SIN inhibition when a mitotic spindle cannot 
form (Murone and Simanis, 1996; Guertin 
et al., 2002). In this report, we show that 
Dma1 exhibits previously unrecognized 
dynamic localization to SPBs and the cell 
division site during anaphase. We found that both the SIN and aut-
oubiquitination modulate Dma1 SPB localization dynamics, and 
therefore its function, in the checkpoint. Further, our data show that 
if Dma1 is prevented from leaving Sid4 on the SPBs, cells fail divi-
sion, indicating that Dma1’s transient loss from SPBs is a critical step 
in cytokinesis and cell survival.
Dma1 division site localization
Though Dma1 was previously shown to localize to the division site 
(Guertin et al., 2002), our time-lapse imaging experiments with the 
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brighter mNG fluorophore (Shaner et al., 
2013) revealed more detail. Dma1-mNG 
initially appears in nodelike structures, rem-
iniscent of cytokinetic precursor nodes 
(Rincon and Paoletti, 2012), before coalesc-
ing into a ring. In addition, Dma1 leaves 
the division site after anaphase B onset and 
before ring constriction and then reap-
pears at the division site before cell divi-
sion. The role of Dma1 at the division site is 
not yet understood, because no binding 
partners or substrates at the medial cortex 
have been identified. Because neither 
Dma1 activity nor the SIN impacts its cell 
division site localization dynamics, a differ-
ent mechanism of targeting to this site 
must be in place. Importantly, tethering 
Dma1 to Sid4 at the SPB using the GBP-
GFP system blocked cytokinesis without 
disrupting Dma1 localization to the division 
site, validating that it is Dma1’s SPB local-
ization that is important for controlling SIN 
function. We also detected Dma1 localiza-
tion to cell tips in this study, but, again, its 
mechanism of targeting and function there 
are not known.
SIN regulation of Dma1 dynamics
Although the transient dip in Dma1 SPB lo-
calization in early anaphase depends on its 
catalytic activity and is independent of SIN 
function, SIN activity is required for Dma1’s 
reaccumulation at SPBs later in anaphase. 
This observation may reflect a change in 
Dma1’s autoubiquitination activity or that of 
a counteracting deubiquitinating enzyme or 
reveals a component of negative feedback 
in which the SIN activates an inhibitor to 
direct its own silencing (Garcia-Cortes and 
McCollum, 2009). Since Dma1 is a phospho-
protein (Koch et al., 2011), it will be interest-
ing to determine the role of phosphoryla-
tion in Dma1 regulation and whether this 
is controlled directly or indirectly by SIN 
kinases.
Dma1 autoubiquitination controls its 
dynamic localization at SPBs
Our data show that Dma1 is capable of 
extensive autoubiquitination in vitro and 
in vivo. Its promiscuous autoubiquitina-
tion, which extended to any tag that we 
tested that includes lysines, complicated 
our investigation of its role as we were un-
able to visualize the dynamic localization 
of a lysine-less, catalytically active Dma1 
protein with confidence in a haploid cell. 
However, we were able to use heterozy-
gous diploids to show that the active form 
of the protein was sufficient to remove the 
inactive form from SPBs during early ana-
phase. Indeed, our data support the idea 
FIGURE 4: Dma1 ubiquitination disrupts its interaction with Sid4. (A) Recombinant Dma1 was 
incubated with E1, Ub, and E2 (+E2) or not (–E2), followed by incubation with biotinylated Sid4 
peptides (either unphosphorylated [Sid4] or phosphorylated [p-Sid4]) conjugated to streptavidin 
beads. Beads only was included as a control. Supernatants (containing unbound Dma1) and 
beads (containing bound Dma1) were recovered, and each was split in half for treatment either 
with H2O, or USP2 to collapse ubiquitinated Dma1 for better detection. The entire samples from 
beads (top panel) and half of the supernatants (lower panel) were resolved by SDS–PAGE and 
detected by immunoblotting with anti-Dma1 serum or streptavidin (for visualization of 
biotinylated peptides). (B) Anti-Ub blotting of the same membranes blotted for anti-Dma1 in A. 
(C) Recombinant Dma1 was incubated with biotinylated phosphorylated Sid4 (p-Sid4) peptides. 
The beads were split in half and subjected to in vitro ubiquitination assay with (+E2) or without 
(–E2) E2 enzyme. Supernatants (containing unbound Dma1) and beads (containing bound Dma1) 
were recovered and each was split in half for treatment with either H2O or USP2. The entire 
samples from beads (top panel) and supernatants (bottom panel) were resolved by SDS–PAGE 
and detected by immunoblotting with anti-Dma1 serum or streptavidin. (D) anti-Ub blotting of 
the same membranes blotted for anti-Dma1 in C.
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that autoubiquitination at the onset of anaphase triggers tran-
sient Dma1 removal from SPBs to allow full SIN activation 
(Figure 7E). Preventing Dma1 from leaving the SPB using the 
GBP trap inhibited the SIN. These results are consistent with the 
role of Dma1 as a SPB-localized SIN antagonist in early mitosis 
whose function must be relieved at the onset of anaphase 
(Guertin et al., 2002; Johnson and Gould, 2011; Johnson et al., 
2013).
FIGURE 5: SPB dynamics of Dma1 relative to SIN components. Images from representative movies of dma1-mNG 
cdc7-mCherry (A) and dma1-mNG sid2-mCherry (C). Time in minutes denoted below images. In A, time 0 indicates 
initial frame of SPB separation while in C, time 0 indicates the beginning of imaging. Scale bars, 5 µm. (B) Enlarged SPB 
region(s) from movie in A. Scale bars, 1 µm. In A and B, boxes indicate initial frame of asymmetric Cdc7 SPB localization. 
In C, the box indicates the first frame Sid2 localization to the division site was detected.
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Degradation of Dma1
Because the catalytically inactive form of Dma1 is more abundant 
than wild type, its levels are clearly regulated by its own activity 
state. While we do not yet know all the factors modulating Dma1 
catalytic activity, our data are consistent with autoubiquitination 
triggering Dma1 destruction. This could happen directly at SPBs, 
analogously to proteasome-mediated degradation of many regu-
latory proteins at centrosomes (Vora and Phillips, 2016), or off the 
centrosome if ubiquitination prevents Dma1 association with its 
SPB tethers, similarly to what has been observed for another SIN 
inhibitor, Byr4 (Krapp et al., 2008). This mechanism of inhibiting 
Dma1, autoubiquitination and self-destruction, may be broadly 
applicable in signaling pathways when the outcome of substrate 
ubiquitination is not degradation and signal flux through a path-
way must be restored rapidly. Dma1 relatives CHFR and RNF8 are 
integral components of checkpoint pathways that undergo autou-
biquitination in vivo and in vitro (Kang et al., 2002; Lok et al., 
2012), but whether this modification is a key step in checkpoint 
silencing in their cases remains to be determined. To fully under-
stand the factors that modulate the Dma1-dependent mitotic 
checkpoint, it will be important to determine how Dma1 autoubiq-
uitination is restrained to allow substrate ubiquitination during 
FIGURE 6: Influence of SIN function on Dma1 localization dynamics. (A) Images from a representative movie of 
dma1-mNG sad1-mCherry cdc7-24 following shift to 36°C for 2 h. Time in minutes denoted below images; time 0 
indicates initial frame of SPB separation. Scale bar, 5 µm. (B) Enlarged SPB region(s) from movie in A. Scale bars, 1 µm. 
(C) Representative live cell image of dma1-mNG sad1-mCherry cdc16-116 shifted to 36°C for 3 h. Scale bar, 10 µm.
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FIGURE 7: Dma1 must leave the SPBs for cytokinesis. (A) Representative live cell images of 
dma1-GFP sid4-GBP-mCherry. (B) Representative DAPI stained images of dma1-GFP sid4-GBP-
mCherry. (C) Representative image of dma1-GFP sid4-GBP cells illustrating “kissing nuclei” 
phenotype indicated with arrows in B and C. Scale bars in A and B, 10 µm; in C, 5 µm. 
(D) Quantification of cells from B and C with 1, 2, and >2 nuclei and separately “kissing nuclei.” 
(E) Cartoon showing the dynamic localization of Dma1 throughout mitosis and cytokinesis. In 
metaphase when the mitotic checkpoint is activated, Dma1 binds and ubiquitinates Sid4. Our 
data indicate that in early anaphase, Dma1 autoubiquitinates and leaves the SPB allowing 
maximal SIN activation and cytokinesis.
early mitosis. It will also be important to understand the check-
point silencing strategies used in other organisms to allow cytoki-
nesis to proceed following chromosome clearance from the 
division site and whether there are parallels with the strategies 
used by fission yeast.
MATERIALS AND METHODS
Yeast
Yeast strains grown in this study (Supple-
mental Table S1) were grown in yeast ex-
tract (YE), 4X concentrated yeast extract 
(4X YE), or minimal media supplemented 
with leucine and uracil for diploid strains 
(Moreno et al., 1991). Genes were tagged 
at the 3′ end of their open reading frame 
with mNG:kanR, mNG:HygR, GFP:kanR, 
mCherry:kanR, mCherry:natR, HBH:kanR, 
HA3-TAP:kanR, GBP-mCherry:kanR, or 
ubp7+ (residues 201–875) DUB:kanR using 
PCR and pFA6 cassettes (Wach et al., 1994; 
Bahler et al., 1998). For gene replace-
ments, a haploid dma1::ura4+ strain was 
transformed with the appropriate pIRT2–
dma1 mutant, and integrants were se-
lected by resistance to 1.5 mg/ml 5-fluo-
roorotic acid and validated by colony PCR 
and DNA sequencing. Diploid strains were 
made by crossing ade6-M210 cells with 
ade6-M216 cells on glutamate plates for 
24–48 h followed by restreaking to single 
colonies on MAU plate and incubating at 
32°C for 3 d. White colonies (diploid cells) 
were then picked for subsequent analysis. 
For spot assays, cells were cultured in YE at 
29°C. Serial 10-fold dilutions of each cul-
ture were made, 3 μl of each dilution was 
spotted on YE plates, and they were incu-
bated at various temperatures for 3–4 d. 
nda3-KM311 cultures were grown at 32°C 
and then shifted to 18°C for 6 h to block in 
prometaphase. mts3-1 cells were grown at 
25°C and then shifted to 36°C for 3.5 h be-
fore imaging or biochemical experiments.
Molecular biology
Plasmids were generated by standard 
molecular biology techniques. dma1 muta-
tions were made either in the context of a 
gene fragment in the pIRT2 vector that in-
cluded 500 base pairs upstream and down-
stream of the open reading frame or in 
the context of the open reading frame in 
pMAL-c2 vector using a QuikChange site-
directed mutagenesis kit (Agilent Technol-
ogies). The K to R mutation abbreviations 
are as follows: Dma1-4KR = K3R, K10R, 
K121R, and K124R; Dma1-9KR = K3R, 
K26R, K54R, K82R, K124R, K164R, K174R, 
K237R, and K262R; Dma1-12KR = Dma1-
4KR mutations plus K22R, K26R, K162R, 
K164R, K174R, K217R, K237R, and K262R; 
Dma1-14KR = Dma1-12KR mutations plus 
K54R, and K82R.
cDNAs encoding Ubp2, Ubp3, Ubp4, Ubp8, Ubp14, Ubp15, 
Ubp16, and Uch1 were amplified by PCR from genomic S. pombe 
DNA using primers containing restriction sites. PCR products were 
digested with restriction enzymes (Nde1/BamHI for ubp2 and ubp3 
and NdeI/XmaI for ubp4, ubp8, ubp14, ubp15, ubp16, and uch1), 
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subcloned into pREP1, and verified by sequencing. DNAs encoding 
Ubp1, Ubp7, Ubp9, Ubp11, Otu1, Otu2, and Sst2 were digested 
from genomic constructs, subcloned into pREP1, and verified by 
sequencing. ubp6 and uch2 cDNAs in pREP1 vectors were gifts 
from Colin Gordon (Stone et al., 2004).
Microscopy
Unless otherwise indicated, all imaging was done at room tempera-
ture on a Personal DeltaVision microscope system (Applied 
Precision) that includes an Olympus IX71 microscope, 60 × NA 1.42 
PlanApo oil immersion objective, standard and live-cell filter wheels, 
a Photometrics CoolSnap HQ2 camera, and softWoRx imaging 
software. For imaging at 36°C, an environmental chamber with 
temperature control was used. Time-lapse imaging was done using 
a CellAsic microfluidic system (EMD Millipore) with appropriate cell 
media. Figure images are maximum intensity projections of z sec-
tions spaced 0.2–0.5 μm apart. Images used for quantification were 
not deconvolved and sum projected.
Intensity measurements were made with ImageJ software (Na-
tional Institutes of Health, Bethesda, MD: http://rsbweb.nih.gov/ij/). 
For all intensity measurements, the background was subtracted by 
calculating a value for background per pixel (BPP) in the same image 
as the region of interest (ROI) where there were no cells. The BPP 
was then multiplied by the area of the ROI, and the resulting prod-
uct was subtracted from the raw integrated intensity of that ROI 
yielding the corrected intensity value (Waters, 2009).
For analysis relative to a SPB marker, an ROI was made based on 
the SPB marker. mNG or GFP fluorescence intensity and mCherry 
marker fluorescence intensity were measured with background cor-
rection for each. Final values for each cell are expressed as mNG/
mCherry or GFP/mCherry ratios. Measurements for the cells in each 
group were averaged for statistical analysis.
Protein purification and mass spectrometry
Endogenously tagged versions of Dma1 (Dma1-HA3-TAP and 
Dma1-HBH) were purified as previously described (Gould et al., 
2004; Tagwerker et al., 2006; Elmore et al., 2014) and analyzed 
by 2D-LC-MS/MS as previously described (McDonald et al., 2002; 
Roberts-Galbraith et al., 2009). RAW files were processed using 
two pipelines: 1) using Myrimatch (v 2.1.132) (Tabb et al., 2007) 
and IDPicker (v 2.6.271.0) (Ma et al., 2009) as previously described 
(McLean et al., 2011) and 2) using turboSEQUEST, Scaffold (v 
4.4.7), and Scaffold PTM (v 3.0.0) as previously described (Beckley 
et al., 2015). We detected the variable di-Gly modification (114 
Da) indicating ubiquitination, and these modifications were manu-
ally validated (representative spectra are shown in Supplemental 
Figure S3).
Protein expression and purification
dma1 variants were cloned into pMAL-c2 or pET-His6-MBP prescis-
sion LIC cloning vector (HMPKS) (HMPKS was a gift from Scott 
Gradia [Addgene plasmid #29721]) for production as MBP fusions. 
Proteins were induced in Escherichia coli Rosetta2(DE3)pLysS cells 
by addition of 0.8 mM isopropyl-β-d-thiogalactopyranoside (IPTG) 
and overnight incubation at 18°C. Cells were lysed using 300 μg/ml 
lysozyme for 20 min followed by sonication. Proteins were affinity 
purified on prewashed amylose resin (New England Biolabs) in 
MBP column buffer (100 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1 mM 
EDTA, 1 mM dithiothreitol [DTT], and 1% Nonidet P-40 [NP-40]). 
Protein was eluted with 10 mM maltose, and, in some cases, the 
MBP tag was cleaved with Factor Xa protease (New England Bio-
labs) or Precission protease (GE Healthcare). Dma1 peak elution 
fraction(s) were detected by SDS–PAGE and Coomassie Blue 
(Sigma) staining. After pooling peak fractions, Dma1 proteins were 
concentrated using a 10 MWCO Amicon Ultra centrifugal filter 
(EMD Millipore). Dma1 was cleaved from MBP by adding 1 μl 
(2 units) of PreScission protease to 500 μg MBP-Dma1 on amylose 
beads (in 200 μl MBP column buffer) and incubating at 4°C over-
night. The supernatant containing cleaved Dma1 was retrieved and 
the concentration of Dma1 was determined by SDS–PAGE using 
bovine serum albumin (BSA) as standard.
In vitro ubiquitination assay
Ubiquitination reactions included: 0.25–1 μg recombinant MBP-
Dma1 (or variant thereof), or Dma1 cleaved from MBP, 175 nM E1 
(R&D Systems), 3 μM E2 (R&D Systems), 50 μg/ml methylated ubiq-
uitin, 5 mM ATP, and 1x ubiquitination buffer (50 mM Tris-HCl, pH 
7.5, 2.5 mM MgCl2, 0.5 mM DTT). These 20 μl reactions were incu-
bated with agitation at 30°C for 90 min before adding SDS sample 
buffer or cleaving Dma1 from MBP. For MBP cleavage, 1.8 μl of 1 M 
CaCl2 and 5 μl Factor Xa were added, and the reactions were incu-
bated at room temperature with agitation for 1 h. Then 100 μl ben-
zamidine beads (1:1 slurry) and 100-μl amylose beads (1:1 slurry) 
(both prewashed in MBP column buffer) were added, and reactions 
were incubated at room temperature with agitation for 45 min. 
Supernatants were transferred to new tubes, and SDS sample buffer 
was added prior to separation by SDS–PAGE. Ubiquitination prod-
ucts and Dma1 were detected by immunoblotting with anti-ubiqui-
tin (EMD Millipore, MAB1510) at a 1:250 dilution or (Life Sensors, 
VU-1) at a 1:500 dilution and/or anti-Dma1 (see Supplemental 
Figure S4E) antibodies.
In vivo ubiquitination assay
Dma1-HBH was purified from 250-ml 4X YE pellets as previously 
described (Tagwerker et al., 2006; Beckley et al., 2015). Briefly, 
cell pellets were washed with 10 ml modified buffer 1 (8 M urea, 
300 mM NaCl, 50 mM NaPO4, 0.5% Nonidet P-40, and 4 mM 
imidazole, pH 8, with 1.3 mM benzamidine, 1 mM PMSF, 50 μM 
PR-619 [LifeSensors], 50 μM N-ethylmaleimide, and 1 Complete 
Protease Inhibitor Cocktail Tablet, EDTA-free [Roche] per 50 ml) 
and then lysed by bead disruption with 500 μl buffer 1. Lysates 
were extracted with 10 ml and then 5 ml buffer 1 (15 ml total ex-
traction), cleared by high-speed centrifugation, and then incu-
bated with 200 μl (1:1 slurry) Ni2+-NTA agarose beads (Qiagen) for 
3–4 h at room temperature. After incubation, beads were washed 
four times: one time with 10 ml buffer 1 and three times with 10 ml 
buffer 3 (8 M urea, 300 mM NaCl, 50 mM NaPO4, 0.5% Nonidet 
P-40, and 20 mM imidazole, pH 6.3). Proteins were then eluted for 
15 min in 5 ml buffer 4 (8 M urea, 200 mM NaCl, 50 mM NaPO4, 
0.5% Nonidet P-40 and 2% SDS, 100 mM Tris, and 10 mM EDTA, 
pH 4.3) two times, and the two eluates were pooled. The pH of the 
final eluate was adjusted to 8 before 80 μl streptavidin ultra-link 
resin (Pierce) was added and incubated overnight at room tem-
perature. The streptavidin beads were then washed three times 
with buffer 6 (8 M urea, 200 mM NaCl, 2% SDS, and 100 mM Tris, 
pH 8). Purified proteins were detected on a Western blot using an 
anti-ubiquitin antibody (EMD Millipore, MAB1510) at a 1:250 dilu-
tion or (Life Sensors, VU-1) at a 1:500 dilution and fluorescently 
labeled streptavidin (Li-COR Biosciences).
Biotinylated peptide conjugation to streptavidin beads
A 50% slurry of Ultralink strepavidin beads (20 μl) was washed in 
200 μl MBP column buffer three times and resuspended in 88 μl 
column buffer. The amount of 2 μg (2 μl of 1 mg/ml) synthetic 
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biotinylated peptides (Genescript) dissolved in 5% acetonitrile was 
added and incubated at 4°C overnight. Beads were then washed in 
200 μl MBP column buffer three times before being resuspended in 
10 μl column buffer.
Sid4 phosphopeptide binding assay
The Sid4 phosphopeptide binding assay was performed as de-
scribed (Johnson et al., 2013) with the following modifications. 
First, 0.5 μg purified recombinant Dma1 (cleaved from MBP-Dma1 
by Precission protease) was ubiquitinated in vitro as described 
above (0.4 μg/μl ubiquitin was used instead of methylated ubiqu-
tin) in the presence (+E2) or absence (–E2) of E2 enzyme in 40 μl 
total volume for 2 h at 30°C. Reactions were stopped by adding 
4 μl 1 M DTT to a final concentration of 91.4 mM. Next, 2.2 μl of 
the reaction mixture containing 25 ng nonubiquitinated (–E2) or 
ubiquitinated (+E2) Dma1 was added to 19.8 μl binding buffer 
(50 mM Tris-HCl, pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT) 
containing streptavidin beads only or 5 μM synthetic biotinylated 
nonphosphorylated Sid4 peptide (bio-LTSSTCVSSISQ) or phos-
phorylated Sid4 peptide (bio-LTSSpT275CVpS278SISQ) (Genescript) 
conjugated on Ultralink streptavidin beads (Pierce) and incubated 
at 4°C for 30 min (beads were preblocked with 50 μl 5% BSA in 
binding buffer for 1 h). The unbound supernatants were recovered, 
split equally into two parts, and treated with 0.33 μl H2O or 1.5 mg/
ml USP2 (Boston Biochem) and analyzed by SDS–PAGE. The beads 
were washed with 1 ml high-salt MBP column buffer (20 mM Tris-
HCl, pH 7.4, 250 mM NaCl, 1 mM EDTA, 0.1% NP-40, 1 mM DTT) 
five times, followed by washing with 0.5 ml deubiquitination buffer 
(50 mM Tris, pH 7.4, 25 mM KCl, 5 mM MgCl2, 10 mM DTT) twice 
prior to being split equally into two parts. Beads were resuspended 
in 19 μl deubiquitination buffer and treated with 0.33 μl H2O or 
USP2. The deubiquitination reactions were incubated with shaking 
at 32°C for 2 h. Reactions were stopped by adding SDS sample 
buffer.
Alternatively, phosphorylated Sid4 peptides on beads (6.25 μM) 
were incubated with 5 ng/μl Dma1 in 200 μl high-salt MBP buffer for 
30 min at 4°C in the presence of 5% BSA, followed by 6 × 1 ml wash 
of high-salt MBP buffer and then with 1 ml of ubiquitination buffer 
twice. Beads were split into two equal parts (for –E2 and +E2) and 
subject to the in vitro ubiquitination assay in 20 μl total volume as 
described above. Reactions were stopped by adding 0.5 μl 1M DTT 
to a final concentration of 24.9 mM. The unbound supernatants 
were recovered and split equally into two parts, and 10 μl of 50 mM 
Tris, 50 mM KCl, 7.5 mM MgCl2 was added (after adjusting the buf-
fer composition is 49.4 mM Tris, 25 mM KCl, 5 mM MgCl2, 12.4 mM 
DTT) prior to being treated with 0.33 μl H2O or 1.5 mg/ml USP2. 
The beads were washed with 1 ml deubiquitination buffer twice and 
split equally into two parts before treatment with H2O or USP2 as 
described above.
Lysis, immunoprecipitation, and immunoblotting
Cell pellets were washed once in NP-40 buffer (10 mM sodium 
phosphate, pH 7.0, 1% N-P-40, 150 mM NaCl, 2 mM EDTA) with 
inhibitors (1.3 mM benzamidine, 1 mM PMSF, and 1 Complete Pro-
tease Inhibitor Cocktail Tablet, EDTA-free [Roche] per 50 ml) and 
lysed by bead disruption. For denaturing lysis, 500 μl SDS lysis 
buffer (10 mM sodium phosphate, pH 7.0, 1% SDS, 1 mM DTT, 
1 mM EDTA, 50 mM NaF, 100 μM sodium orthovanadate, 1 mM 
PMSF, and 4 μg/ml leupeptin) was added, and the sample was in-
cubated at 95°C for 2 min, and lysate was extracted with 800 μl 
NP-40 buffer and transferred to a clean tube. For native lysis, the 
lysate was extracted with 500 μl NP-40 buffer and again with 800 μl 
and then transferred to a clean tube. Extractions were followed by 
two clearing spins of 5 and 30 min. Proteins were immunoprecipi-
tated from native protein lysates using an excess of antibody 
(listed below) and rocking at 4°C for 1 h, followed by addition of 
Protein A or G Sepharose beads (GE Healthcare), as appropriate, 
and rocking at 4°C for 30 min. Samples were washed four times 
with NP-40 buffer. Antibodies: 0.8 μg anti-GFP (Roche), 2 μg anti-
FLAG (Sigma-Aldrich), 3 μl rabbit anti-Sid4 antiserum, or 2 μl rab-
bit anti-Dma1 serum.
Antisera were raised against recombinant GST-mNG or GST-
Dma1 (Cocalico), and their specificity was verified by immunoblot-
ting (Figure 2 and Supplemental Figure S4E, respectively). The 
anti-Dma1 serum was further purified by ammonium sulfate pre-
cipitation. The serum was cleared by centrifugation and then pre-
cipitated with 0.5 volumes of saturated ammonium sulfate added 
dropwise and incubated overnight at 4°C. The precipitate was 
cleared from the serum by centrifugation and then the serum was 
precipitated with an additional 0.5 volumes of saturated ammo-
nium sulfate added dropwise and incubated overnight at 4°C. The 
precipitate was pelleted by centrifugation, resuspended in 0.4 vol-
umes phosphate-buffered saline (PBS), and dialyzed three times in 
PBS.
For lambda phosphatase treatment, immunoprecipitated pro-
tein was washed twice with 25 mM HEPES-NaOH (pH 7.4) and 
150 mM NaCl and then treated with lambda phosphatase (New 
England Biolabs) in 1x NEBuffer for PMP and 1 mM MnCl2 and incu-
bated at 30°C for 30–60 min with agitation.
For immunoblotting, proteins were resolved by PAGE (see 
below), transferred to a polyvinylidene difluoride membrane (Im-
mobilon FL; EMD Millipore), blocked with Odyssey Blocking Buffer 
(LI-COR Biosciences), and incubated with primary antibody at 
2 μg/ml or 1:5000 anti-Dma1 serum or 1:2000 anti-Sid4 serum over-
night at 4°C. Primary antibodies were detected with secondary 
antibodies coupled to IRDye680 or IRDye800 (LI-COR Biosciences, 
Lincoln, NE) and visualized using an Odyssey Infrared Imaging Sys-
tem (LI-COR Biosciences). Resolving gels: 3–8% Tris-acetate PAGE 
used for Dma1-FLAG and Sid4-DUB blotting; 4–12% NuPAGE used 
for Dma1-GFP, Sid4, and Dma1 ubiquitination assay blotting, 12% 
Tris-glycine PAGE used for Cdc2 blotting.
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